title: Lenalidomide therapy in systemic mastocytosis.
authors.forename: Hanneke C
authors.initials: HC
authors.lastname: Kluin-Nelemans
authors.forename: Veronika
authors.initials: V
authors.lastname: Ferenc
authors.forename: Jaap J
authors.initials: JJ
authors.lastname: van Doormaal
authors.forename: Charlotte
authors.initials: C
authors.lastname: van Iperen
authors.forename: Willem G
authors.initials: WG
authors.lastname: Peters
authors.forename: Cem
authors.initials: C
authors.lastname: Akin
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008407:Mast Cells / Q000187:drug effects; D034721:Mastocytosis, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D009101:Multiple Myeloma; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide